• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

Arterial hypertension is the most prevalent modifiable risk factor associated with
cardiovascular morbidity and mortality. Although antihypertensive drugs are widely …

Document Reviewers: Luis Alcocer (Mexico), Christina Antza (Greece), Mustafa Arici
(Turkey), Eduardo Barbosa (Brazil), Adel Berbari (Lebanon), Luıs Bronze (Portugal), John …

Document Reviewers: Luis Alcocer (Mexico), Christina Antza (Greece), Mustafa Arici
(Turkey), Eduardo Barbosa (Brazil), Adel Berbari (Lebanon), Luıs Bronze (Portugal), John …

Proceedings from the 3rd European Clinical Consensus Conference for clinical trials in
device-based hypertension therapies | European Heart Journal | Oxford Academic Skip to Main …

In the past decade, efforts to improve blood pressure control have looked beyond
conventional approaches of lifestyle modification and drug therapy to embrace …

Patients with arterial hypertension frequently manifest various cardiac rhythm disturbances,
ranging from bradyarrhythmias to supraventricular premature beats, atrial fibrillation, or other …

Background In prior unblinded studies, cardiac neuromodulation therapy (CNT) employing a
sequence of variably timed short and longer atrioventricular intervals yielded sustained …

Abstract Purpose of Review To give an overview on recent developments in permanent
implant-based therapy of resistant hypertension. Recent Findings The American Heart …

More than 1.5 billion people worldwide have arterial hypertension. Hypertension increases
the risks of death and cardiovascular disease, such as atrial fibrillation and heart failure. The …